BioMerieux Fully Acquires Canada Tech Biz Lumed For €9M
By Najiyya Budaly ( January 8, 2024, 11:03 AM GMT) -- French biotechnology company BioMerieux said Monday that it has boosted its 16% stake in a Canadian clinical software business to 100% for approximately €9 million ($9.8 million) in a move to offer products to hospitals designed to prevent antimicrobial resistance in patients....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.